[1]HAAS JT,FRANCQUE S,STAELS B.Pathophysiology and mechanisms of nonalcoholic fatty liver disease[J].Annu Rev Physiol,2016,78(1):181-205.
|
[2]YOUNOSSI ZM,KOENIG AB,ABDELATIF D,et al.Global epidemiology of non-alcoholic fatty liver disease-meta-analytic assessment of prevalence,incidence and outcomes[J].Hepatology,2016,64(1):73-84.
|
[3]ZHANG F,HUANG YQ,BAO ZJ.Prevalence of nonalcoholic fatty liver disease in urban areas in China[J].Chin J Dig,2014,34(6):430-432.(in Chinese)张帆,黄一沁,保志军.非酒精性脂肪性肝病在我国城市地区的流行现状[J].中华消化杂志,2014,34(6):430-432.
|
[4]LIAO XH,CAO X,LIU J,et al.Prevalence and features of fatty liver detected by physical examination in Guangzhou[J].World JGastroenterol,2013,19(32):5334-5339.
|
[5]ANGULO P,KLEINER DE,DAM-LARSEN S,et al.Liver fibrosis,but no other histologic features,is associated with long-term outcomes of patients with nonalcoholic fatty liver disease[J].Gastroenterology,2015,149(2):389-397.
|
[6]EKSTEDT M,HAGSTROM H,NASR P,et al.Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up[J].Hepatology,2015,61(5):1547-1554.
|
[7]BEDOSSA P,PATEL K.Biopsy and noninvasive methods to assess progression of nonalcoholic fatty liver disease[J].Gastroenterology,2016,150(8):1811-1822.e4.
|
[8]SHI KQ,TANG JZ,ZHU XL,et al.Controlled attenuation parameter for the detection of steatosis severity in chronic liver disease:a meta-analysis of diagnostic accuracy[J].J Gastroenterol Hepatol,2014,29(6):1149-1158.
|
[9]BERZIGOTTI A.Getting closer to a point-of-care diagnostic assessment in patients with chronic liver disease:controlled attenuation parameter for steatosis[J].J Hepatol,2014,60(5):910-912.
|
[10]LEDINGHEN V,WONG G L,VERGNIOL J,et al.Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease[J].J Gastroenterol Hepatol,2016,31(4):848-855.
|
[11]SON JY,LEE JY,YI NJ,et al.Hepatic steatosis:assessment with acoustic structure quantification of us imaging[J].Radiology,2016,278(1):257-264.
|
[12]ZHANG B,DING F,CHEN T,et al.Ultrasound hepatic/renal ratio and hepatic attenuation rate for quantifying liver fat content[J].World J Gastroenterol,2014,20(47):17985-17992.
|
[13]VUPPALANCHI R,CUMMINGS OW,SAXENA R,et al.Relationship among histologic,radiologic,and biochemical assessments of hepatic steatosis:a study of human liver samples[J].J Clin Gastroenterol,2007,41(2):206-210.
|
[14]LE TA,CHEN J,CHANGCHIEN C,et al.Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis:a randomized controlled trial[J].Hepatology,2012,56(3):922-932.
|
[15]NOUREDDIN M,LAM J,PETERSON MR,et al.Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials[J].Hepatology,2013,58(6):1930-1940.
|
[16]MEISAMY S,HINES CD,HAMILTON G,et al.Quantification of hepatic steatosis with T1-independent,T2-corrected MR imaging with spectral modeling of fat:blinded comparison with MR spectroscopy[J].Radiology,2011,258(3):767-775.
|
[17]IDILMAN I S,ANIKTAR H,IDILMAN R,et al.Hepatic steatosis:quantification by proton density fat fraction with MR imaging versus liver biopsy[J].Radiology,2013,267(3):767-775.
|
[18]TANG A,DESAI A,HAMILTON G,et al.Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease[J].Radiology,2015,274(2):416-425.
|
[19]BANNAS P,KRAMER H,HERNANDO D,et al.Quantitative magnetic resonance imaging of hepatic steatosis:validation in ex vivo human livers[J].Hepatology,2015,62(5):1444-1455.
|
[20]SOLIMAN AS,YUAN J,VIGEN KK,et al.Max-IDEAL:a max-flow based approach for IDEAL water/fat separation[J].Magn Reson Med,2014,72(2):510-521.
|
[21]HU HH,KIM HW,NAYAK KS,et al.Comparison of fat-water MRI and single-voxel MRS in the assessment of hepatic and pancreatic fat fractions in humans[J].Obesity(Silver Spring),2010,18(4):841-847.
|
[22]IDILMAN IS,TUZUN A,SAVAS B,et al.Quantification of liver,pancreas,kidney,and vertebral body MRI-PDFF in non-alcoholic fatty liver disease[J].Abdom Imaging,2015,40(6):1512-1519.
|
[23]KWOK R,TSE YK,WONG GL,et al.Systematic review with metaanalysis:non-invasive assessment of non-alcoholic fatty liver disease-the role of transient elastography and plasma cytokeratin-18 fragments[J].Aliment Pharmacol Ther,2014,39(3):254-269.
|
[24]MAHADEVA S,MAHFUDZ AS,VIJAYANATHAN A,et al.Performance of transient elastography(TE)and factors associated with discordance in non-alcoholic fatty liver disease[J].J Dig Dis,2013,14(11):604-610.
|
[25]WONG VW,VERGNIOL J,WONG GL,et al.Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease[J].Hepatology,2010,51(2):454-462.
|
[26]TAPPER EB,CHALLIES T,NASSER I,et al.The performance of vibration controlled transient elastography in a us cohort of patients with nonalcoholic fatty liver disease[J].Am J Gastroenterol,2016,111(5):677-684.
|
[27]de LEDINGHEN V,WONG VW,VERGNIOL J,et al.Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement:comparison between M and XL probe of FibroS can(R)[J].J Hepatol,2012,56(4):833-839.
|
[28]MYERS RP,POMIER-LAYRARGUES G,KIRSCH R,et al.Feasibility and diagnostic performance of the FibroS can XL probe for liver stiffness measurement in overweight and obese patients[J].Hepatology,2012,55(1):199-208.
|
[29]WONG VW,VERGNIOL J,WONG GL,et al.Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease[J].Am J Gastroenterol,2012,107(12):1862-1871.
|
[30]LIU H,FU J,HONG R,et al.Acoustic radiation force impulse elastography for the non-invasive evaluation of hepatic fibrosis in non-alcoholic fatty liver disease patients:a systematic review&Meta-analysis[J].PLoS One,2015,10(7):e127782.
|
[31]FRIEDRICH-RUST M,ROMEN D,VERMEHREN J,et al.A-coustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD[J].Eur J Radiol,2012,81(3):e325-e331.
|
[32]SINGH S,VENKATESH SK,LOOMBA R,et al.Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease:a diagnostic accuracy systematic review and individual participant data pooled analysis[J].Eur Radiol,2016,26(5):1431-1440.
|
[33]IMAJO K,KESSOKU T,HONDA Y,et al.Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease Than Transient Elastography[J].Gastroenterology,2016,150(3):626-637.
|
[34]CUI J,HEBA E,HERNANDEZ C,et al.Magnetic resonance elastography is superior to acoustic radiation force impulse for the diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease:a prospective study[J].Hepatology,2016,63(2):453-461.
|
[35]LOOMBA R,CUI J,WOLFSON T,et al.Novel 3D magnetic resonance elastography for the noninvasive diagnosis of advanced fibrosis in nafld:a prospective study[J].Am J Gastroenterol,2016,111(7):986-994.
|